Arkolith/Insider Trading/ATXS/Form 4

Perceptive Xontogeny Venture Fund, LP

DirectorAstria Therapeutics, Inc. (ATXS) · full profile →Form 4 · filed Feb 5, 2024
Net Buying
Open-Market Buys
$30.0M
Open-Market Sells
$0
Net Open-Market Flow
$30.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2024Buy(P)2.5M$12.09$30.0M4.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-001979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML